Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1278
https://www.valueinhealthjournal.com/article/S1098-3015(16)32644-4/fulltext
Title : Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32644-4&doi=10.1016/j.jval.2016.09.1278
First page : A567
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1198
Categories :
Tags :
Regions :
ViH Article Tags :